Biden to tap prominent Harvard cancer surgeon to head National Cancer Institute
President Joe Biden is expected to pick cancer surgeon Monica Bertagnolli as the next director of the National Cancer Institute (NCI). Bertagnolli, a physician-scientist at the Dana-Farber Cancer Institute in Boston and Harvard Medical School, specializes in gastrointestinal cancers and is well known for her expertise in clinical trials. She will replace Ned Sharpless, who
stepped down
as NCI director in April after nearly 5 years.
The White House has not yet announced the selection,
first reported by
STAT
, but several cancer research organizations closely watching for the nomination have issued statements supporting Bertagnolli’s expected selection. She is “a national leader” in clinical cancer research and “a great person to take the job,” Sharpless told
Science
Insider.
With a budget of $7 billion, NCI is the largest component of the National Institutes of Health (NIH) and the world’s largest funder of cancer research. Its director is the only NIH institute director selected by the president. Bertagnolli’s expected appointment, which does not require Senate confirmation, drew applause from the cancer research community
Margaret Foti, chief executive officer of the American Association for Cancer Research, praised Bertagnolli’s "appreciation for … basic research” and “commitment to ensuring that such treatment innovations reach patients … across the United States.” Ellen Sigal, chair and fou...
Source: ScienceNOW - Category: Science Source Type: news
More News: Allergy & Immunology | Budgets | Cancer | Cancer & Oncology | Clinical Trials | Colorectal Cancer | Funding | Gastroenterology | Genetics | Grants | Harvard | National Institutes of Health (NIH) | Physics | Science | USA Health